|
US2776145A
(en)
*
|
1952-01-23 |
1957-01-01 |
Caltagirone |
Phonograph tablet tables
|
|
US2766146A
(en)
|
1954-07-26 |
1956-10-09 |
Reynolds Tobacco Co R |
Tobacco
|
|
US2766145A
(en)
|
1954-07-26 |
1956-10-09 |
Reynolds Tobacco Co R |
Tobacco
|
|
US3053677A
(en)
|
1959-11-12 |
1962-09-11 |
Eastman Kodak Co |
Petroleum wax for paper coatings
|
|
US4346107A
(en)
|
1979-02-12 |
1982-08-24 |
Claudio Cavazza |
Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
|
|
FR2490631A1
(fr)
|
1980-09-24 |
1982-03-26 |
Roussel Uclaf |
Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
|
|
US4528197A
(en)
|
1983-01-26 |
1985-07-09 |
Kabivitrum Ab |
Controlled triglyceride nutrition for hypercatabolic mammals
|
|
US4551523A
(en)
|
1983-04-14 |
1985-11-05 |
Eastman Kodak Company |
Preparation of saccharide acetoacetates
|
|
US4847296A
(en)
|
1984-09-13 |
1989-07-11 |
Babayan Vigen K |
Triglyceride preparations for the prevention of catabolism
|
|
US4687782A
(en)
|
1984-12-10 |
1987-08-18 |
Nutri-Fuels Systems, Inc. |
Nutritional composition for enhancing skeletal muscle adaptation to exercise training
|
|
US5126373A
(en)
*
|
1987-11-19 |
1992-06-30 |
Henri Brunengraber |
Composition for parenteral and oral nutrition
|
|
SE8803141L
(sv)
|
1988-09-07 |
1990-03-08 |
Kabivitrum Ab |
Naeringsmedel foer maenniskor och djur
|
|
US5118670A
(en)
|
1988-12-14 |
1992-06-02 |
Massachusetts Institute Of Technology |
Process and composition for increasing brain dopamine release
|
|
US5650148A
(en)
|
1988-12-15 |
1997-07-22 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
|
|
DE3843238C1
(https=)
|
1988-12-22 |
1990-02-22 |
Lohmann Therapie Syst Lts |
|
|
IT1240775B
(it)
|
1990-02-23 |
1993-12-17 |
Sigma Tau Ind Farmaceuti |
Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
|
|
DE69108239T2
(de)
|
1990-04-26 |
1995-09-28 |
Procter & Gamble |
Polyol-fettsäure-polyester enthaltende backfettzusammensetzungen.
|
|
US5538983A
(en)
|
1990-05-16 |
1996-07-23 |
The Rockefeller University |
Method of treating amyloidosis by modulation of calcium
|
|
US5385915A
(en)
|
1990-05-16 |
1995-01-31 |
The Rockefeller University |
Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
|
|
US5175190A
(en)
|
1991-02-15 |
1992-12-29 |
The University Of British Columbia |
Medium chain fatty acids of C8-10 for the treatment of skin lesions
|
|
US5614560A
(en)
|
1991-04-04 |
1997-03-25 |
Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
GB9113484D0
(en)
|
1991-06-21 |
1991-08-07 |
Unilever Plc |
Cosmetic composition
|
|
US5276059A
(en)
|
1992-07-10 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibition of diseases associated with amyloid formation
|
|
US5308832A
(en)
|
1992-07-27 |
1994-05-03 |
Abbott Laboratories |
Nutritional product for persons having a neurological injury
|
|
JP3265577B2
(ja)
|
1992-10-13 |
2002-03-11 |
デューク・ユニバーシティ |
アポリポ蛋白ｅの４型イソ型の測定法
|
|
US5494794A
(en)
|
1992-10-20 |
1996-02-27 |
Emory University |
Detection of mitochondrial DNA mutations associated with Alzheimer's disease and Parkinson's disease
|
|
JP3486778B2
(ja)
*
|
1993-04-02 |
2004-01-13 |
三菱ウェルファーマ株式会社 |
アルツハイマー病予防治療剤
|
|
WO1995009144A1
(en)
|
1993-09-30 |
1995-04-06 |
Eastman Chemical Company |
Nutritive water soluble glycerol esters of hydroxy butyric acid
|
|
US5420335A
(en)
*
|
1993-09-30 |
1995-05-30 |
Birkhahn; Ronald H. |
Parenteral nutrients based on watersoluble glycerol bisacetoacetates
|
|
US5438042B1
(en)
|
1993-10-08 |
1997-08-26 |
Sandoz Nutrition Ltd |
Enteral nutritional composition having amino acid profile
|
|
JP3645580B2
(ja)
|
1993-10-22 |
2005-05-11 |
株式会社フジモト・ブラザーズ |
グルコースエステル誘導体を含有する脳代謝改善剤
|
|
US5691325A
(en)
|
1994-01-14 |
1997-11-25 |
Sandyk; Reuven |
Method for ameliorating age-related disease conditions
|
|
GB9408465D0
(en)
|
1994-04-27 |
1994-06-22 |
Univ Mcgill |
Apolipoprotein e polymorphism & treatment of alzheimer's disease
|
|
US7049078B2
(en)
|
1994-04-27 |
2006-05-23 |
Judés Poirier |
Apolipoprotein E polymorphism and treatment of alzheimer's disease
|
|
US5607967A
(en)
|
1994-10-27 |
1997-03-04 |
Merck & Co., Inc. |
Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
|
|
ATE332127T1
(de)
|
1994-11-08 |
2006-07-15 |
Avicena Group Inc |
Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
|
|
US5854204A
(en)
|
1995-03-14 |
1998-12-29 |
Praecis Pharmaceuticals, Inc. |
Aβ peptides that modulate β-amyloid aggregation
|
|
US5854215A
(en)
|
1995-03-14 |
1998-12-29 |
Praecis Pharmaceuticals Incorporated |
Modulators of β-amyloid peptide aggregation
|
|
US5817626A
(en)
|
1995-03-14 |
1998-10-06 |
Praecis Pharmaceuticals Incorporated |
Modulators of beta-amyloid peptide aggregation
|
|
US6022683A
(en)
|
1996-12-16 |
2000-02-08 |
Nova Molecular Inc. |
Methods for assessing the prognosis of a patient with a neurodegenerative disease
|
|
US5635199A
(en)
|
1995-10-27 |
1997-06-03 |
Nestec Ltd. |
Support of pediatric patients
|
|
JP4598203B2
(ja)
|
1995-12-01 |
2010-12-15 |
ビーティージー・インターナショナル・リミテッド |
脳機能改善剤
|
|
US5936078A
(en)
|
1995-12-12 |
1999-08-10 |
Kyowa Hakko Kogyo Co., Ltd. |
DNA and protein for the diagnosis and treatment of Alzheimer's disease
|
|
DE19609476A1
(de)
|
1996-03-11 |
1997-09-18 |
Basf Ag |
Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
|
|
IT1284650B1
(it)
|
1996-05-24 |
1998-05-21 |
Sigma Tau Ind Farmaceuti |
Farmaco a base di un derivato della carnitina per il trattamento della demenza di alzheimer in pazienti ad insorgenza precoce della patologia
|
|
KR980008239A
(ko)
|
1996-07-26 |
1998-04-30 |
김충환 |
사이클로스포린-함유 약학적 조성물
|
|
EP1006794B1
(en)
|
1997-03-12 |
2007-11-28 |
Robert W. Esmond |
A method for treating or preventing alzheimer's disease
|
|
US6316038B1
(en)
|
1997-03-17 |
2001-11-13 |
Btg International Limited |
Therapeutic compositions
|
|
CA2283642C
(en)
|
1997-03-17 |
2012-05-15 |
Btg International Limited |
Therapeutic compositions
|
|
US6323237B1
(en)
|
1997-03-17 |
2001-11-27 |
Btg International Limited |
Therapeutic compositions
|
|
US6352722B1
(en)
|
1997-12-23 |
2002-03-05 |
Quadrant Holdings Cambridge Limited |
Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
|
|
US20040058873A1
(en)
|
1998-03-12 |
2004-03-25 |
Esmond Robert W. |
Method for treating or preventing Alzheimer's disease
|
|
WO1999051097A1
(en)
|
1998-04-02 |
1999-10-14 |
Avicena Group, Inc. |
Compositions containing a combination of a creatine compound and a second agent
|
|
US6159942A
(en)
|
1998-06-19 |
2000-12-12 |
Bioenergy, Inc. |
Compositions for increasing energy in vivo
|
|
US6380244B2
(en)
|
1998-07-22 |
2002-04-30 |
Metabolix, Inc. |
Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
|
|
US6395306B1
(en)
|
1998-09-14 |
2002-05-28 |
Pan Pacific Pharmaceuticals, Inc. |
Bee venom protein and gene encoding same
|
|
WO2000015216A1
(en)
|
1998-09-15 |
2000-03-23 |
Btg International Limited |
Therapeutic compositions (ii)
|
|
GB9908202D0
(en)
|
1999-04-12 |
1999-06-02 |
Unilever Plc |
Cosmetic compositions
|
|
US6835750B1
(en)
|
2000-05-01 |
2004-12-28 |
Accera, Inc. |
Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
|
|
US8124589B2
(en)
|
2000-05-01 |
2012-02-28 |
Accera, Inc. |
Use of ketogenic compounds for treatment of age-associated memory impairment
|
|
US20070179197A1
(en)
|
2000-05-01 |
2007-08-02 |
Accera, Inc. |
Compositions and methods for improving or preserving brain function
|
|
US20020006959A1
(en)
|
2000-05-01 |
2002-01-17 |
Henderson Samuel T. |
Use of medium chain triglycerides for the treatment and prevention of Alzheimer's Disease and other diseases resulting from reduced Neuronal Metabolism
|
|
DE20012857U1
(de)
|
2000-07-27 |
2000-11-09 |
Sportmedizin Team Vertriebs Gmbh, Berneck |
Diätetisches Lebensmittel zum Fettabbau
|
|
US6667397B2
(en)
|
2000-08-25 |
2003-12-23 |
Eastman Chemical Company |
Methods of preparing disaccharide and trisaccharide C6-C12 fatty acid esters with high alpha content and materials therefrom
|
|
GB2368011A
(en)
|
2000-10-17 |
2002-04-24 |
Unilever Plc |
Fatty acid esters of maltose and uses thereof
|
|
US20020103139A1
(en)
|
2000-12-01 |
2002-08-01 |
M. Weisspapir |
Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control
|
|
KR100479741B1
(ko)
|
2000-12-30 |
2005-03-30 |
주식회사 엘지생활건강 |
글루코오스 아실화 유도체 또는 수크로오스 아실화유도체를 함유하는 피부미백제
|
|
WO2002098398A1
(en)
|
2001-06-07 |
2002-12-12 |
Eisai Co., Ltd. |
Methods for preventing and treating diseases and conditions associated with cellular stress
|
|
JP2003048831A
(ja)
|
2001-08-02 |
2003-02-21 |
Suntory Ltd |
脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
|
|
US20030059824A1
(en)
|
2001-09-21 |
2003-03-27 |
Accera, Inc. |
Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
|
|
AU2002364945A1
(en)
|
2001-10-25 |
2003-07-09 |
Neurogenetics, Inc. |
Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
|
|
GB0128510D0
(en)
|
2001-11-28 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
|
JP2005534710A
(ja)
|
2002-08-07 |
2005-11-17 |
ノバルティス アクチエンゲゼルシャフト |
Ａｐｏｅ遺伝子型を基準とした痴呆を処置するための方法
|
|
AU2003268235A1
(en)
|
2002-09-09 |
2004-03-29 |
Mitochroma Research, Inc. |
Compositions and methods for treating niddm and other conditions and disorders associated with ampk regulation
|
|
US6884454B2
(en)
|
2002-10-21 |
2005-04-26 |
Julio Lionel Pimentel |
Appetite suppressing diet bar
|
|
US20050031651A1
(en)
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
EP1605950A4
(en)
|
2003-03-06 |
2008-01-09 |
Accera Inc |
NOVEL CHEMICAL ENTITIES AND METHODS OF USE IN THE TREATMENT OF METABOLIC DISORDERS
|
|
EP1648952B1
(en)
|
2003-06-03 |
2018-03-07 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
|
|
US20050013884A1
(en)
|
2003-07-16 |
2005-01-20 |
Rennels M. Scott |
Compositions and methods for treating heart disease
|
|
US7148192B2
(en)
|
2004-01-29 |
2006-12-12 |
Ebwe Pharma Ges. M.H. Nfg.Kg |
Neuroprotective dietary supplement
|
|
CA2565968C
(en)
|
2004-05-30 |
2013-01-08 |
Sloan-Kettering Institute For Cancer Research |
Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin
|
|
JP2006287138A
(ja)
|
2005-04-05 |
2006-10-19 |
Mitsubishi Materials Corp |
受動部品形成用積層フィルム及びシート型受動部品並びにその製造方法
|
|
US20060252775A1
(en)
|
2005-05-03 |
2006-11-09 |
Henderson Samuel T |
Methods for reducing levels of disease associated proteins
|
|
US8227408B2
(en)
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
NZ569235A
(en)
|
2005-12-15 |
2011-12-22 |
Nestec Sa |
Compositions and methods for preserving brain function using medium chain triglycerides
|
|
US20070173602A1
(en)
|
2006-01-25 |
2007-07-26 |
Brinkman Larry F |
Encapsulated Michael addition catalyst
|
|
US7807718B2
(en)
*
|
2006-06-30 |
2010-10-05 |
Sami A. Hashim |
Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
|
|
JP2008104359A
(ja)
|
2006-10-23 |
2008-05-08 |
Dainippon Ink & Chem Inc |
酵素固定用担体、固定化酵素および酵素固定用担体の製造方法
|
|
KR101335021B1
(ko)
|
2007-07-31 |
2013-12-12 |
액세라인크 |
게놈 테스트의 용도 및 인지 기능 저하 치료용 케톤성 화합물
|